Preferred Label : antiretroviral therapy, highly active;
MeSH definition : Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication.
The regimens usually involve administration of three or more different drugs including
a protease inhibitor.;
MeSH synonym : haart; highly active antiretroviral therapy;
MeSH hyponym : Antiretroviral Therapies, Combination; Antiretroviral Therapy, Combination; Combination Antiretroviral Therapies; Therapies, Combination Antiretroviral; Therapy, Combination Antiretroviral;
MeSH annotation : IM when general; NIM when with specific drugs;
Wikipedia link : https://en.wikipedia.org/wiki/Antiretroviral therapy, highly active;
Origin ID : D023241;
UMLS CUI : C0887947;
Allowable qualifiers
Currated CISMeF NLP mapping
MedlinePlus topic(s)
Record concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication.
The regimens usually involve administration of three or more different drugs including
a protease inhibitor.
https://www.cochrane.org/fr/CD013799/AIRWAYS_quest-ce-que-la-tritherapie-inhalee-quand-est-elle-utilisee-et-quel-est-son-role-dans-lasthme
2022
United Kingdom
review of literature
french abstract
role
asthma
administration, inhalation
nebulizers and vaporizers
asthma, nos
inspiration
asthma
Asthma
antiretroviral therapy, highly active
inhalers
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-gabriel-girard
2022
France
audiovisual aids
chemical element, nos
elements
association
antiretroviral therapy, highly active
---
http://publications.msss.gouv.qc.ca/msss/document-000733/
http://publications.msss.gouv.qc.ca/msss/document-000734/
2022
false
Canada
French
medication adherence
antiretroviral therapy, highly active
hiv infections
viral load
adult
quebec
HIV
anti-hiv agents
anti-hiv agents
acute disease
chronic disease
pregnancy
treatment failure
Pregnant People
infant, newborn
cesarean section
anti-hiv agents
drug interactions
anti-hiv agents
cd4 lymphocyte count
signs and symptoms
hiv infections
comorbidity
hepatitis, viral, animal
neoplasms
anti-hiv agents
guideline
table
---
https://www.ssmg.be/wp-content/uploads/RMG/377/RMG377_06-12.pdf
2021
Belgium
journal article
Intertrochanteric fracture
antiretroviral therapy, highly active
inspiration
pulmonary disease, chronic obstructive
nebulizers and vaporizers
chronic obstructive lung disease, nos
administration, inhalation
inhalers
---
https://cns.sante.fr/actualites/prise-en-charge-du-vih-recommandations-du-groupe-dexperts/
2019
false
false
false
false
France
French
hiv infections
anti-hiv agents
adult
practice guideline
anti-hiv agents
coinfection
hepatitis C, chronic
drug interactions
hepatitis C, chronic
antiviral agents
antiviral agents
hepatitis C
acute disease
algorithms
hepatitis B, chronic
HIV seropositivity
antiretroviral therapy, highly active
drug resistance, viral
blood-borne pathogens
neoplasms
quality of life
health services accessibility
---
https://minerva-ebp.be/FR/Analysis/438
2016
false
false
false
Belgium
French
french abstract
meta-analysis
disease eradication
helicobacter infections
treatment outcome
antiretroviral therapy, highly active
helicobacter pylori
---
http://www.avisdexperts.ch/videos/view/3610/1/a%3A1%3A%7Bs%3A3%3A%22Tag%22%3Ba%3A1%3A%7Bi%3A0%3Bs%3A5%3A%22SANTE%22%3B%7D%7D
2015
false
false
false
Switzerland
French
antiretroviral therapy, highly active
acquired immunodeficiency syndrome
video recording
---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2014.01805/
2014
false
Switzerland
French
Post-Exposure prophylaxis
journal article
practice guideline
acquired immunodeficiency syndrome
hiv infections
antiretroviral therapy, highly active
anti-hiv agents
Sexual Health
---
http://www.cochrane.org/fr/CD008270
2013
United Kingdom
France
French
review of literature
hiv infections
treatment outcome
antiretroviral therapy, highly active
anti-hiv agents
abacavir
dideoxynucleosides
french abstract
---
http://www.cochrane.org/fr/CD002037
2012
United Kingdom
France
French
french abstract
review of literature
hiv infections
anti-hiv agents
treatment outcome
drug therapy, combination
antiretroviral therapy, highly active
comparative study
---
http://www.cochrane.org/fr/CD008740
2011
false
true
false
France
United Kingdom
Tenofovir
treatment outcome
review of literature
french abstract
zidovudine
antiretroviral therapy, highly active
hiv infections
---
https://sante.gouv.fr//IMG/pdf/00_Page_de_titre_composition_du_groupe_d_experts_et_des_sous_groupes_de_travail.pdf
2008
true
false
France
French
hiv infections
mass screening
antiretroviral therapy, highly active
hiv infections
adult
antiretroviral therapy, highly active
pregnancy
infectious disease transmission, vertical
reproductive techniques, assisted
child
adolescent
anti-retroviral agents
drug resistance, viral
HIV-1
HIV-2
comorbidity
hepatitis
neoplasms
quality of life
hiv infections
continuity of patient care
hiv infections
occupational exposure
health behavior
aids-related opportunistic infections
anti-hiv agents
anti-hiv agents
acquired immunodeficiency syndrome
acquired immunodeficiency syndrome
practice guideline
---
http://www.has-sante.fr/portail/display.jsp?id=c_634723
2007
true
France
French
hiv infections
hiv infections
antiretroviral therapy, highly active
health education
antiretroviral therapy, highly active
comorbidity
tuberculosis
hepatitis, viral, human
sexually transmitted diseases
vaccination
continuity of patient care
neoplasms
mass screening
medication adherence
anti-hiv agents
patient care management
practice guideline
---
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/044000467.pdf
2004
France
French
Therapy cessation
skin biopsy
acquired immunodeficiency syndrome
hiv infections
france
acquired immunodeficiency syndrome
hiv infections
population surveillance
mass screening
hiv infections
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
anti-hiv agents
anti-hiv agents
patient selection
antiretroviral therapy, highly active
antiretroviral therapy, highly active
risk factors
patient education as topic
anti-hiv agents
continuity of patient care
treatment outcome
medical history taking
physical examination
hiv infections
acquired immunodeficiency syndrome
hiv infections
acquired immunodeficiency syndrome
communication
treatment failure
hiv infections
acquired immunodeficiency syndrome
drug resistance, viral
microbial sensitivity tests
predictive value of tests
microbial sensitivity tests
microbial sensitivity tests
anti-hiv agents
dose-response relationship, drug
anti-hiv agents
drug interactions
anti-hiv agents
quality control
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
hiv-associated lipodystrophy syndrome
Plastic Surgery Procedures
glucose intolerance
hyperinsulinism
diabetes mellitus
glucose intolerance
diabetes mellitus
hyperinsulinism
glucose intolerance
diabetes mellitus
hyperinsulinism
glucose intolerance
hyperinsulinism
diabetes mellitus
hypertriglyceridemia
hypercholesterolemia
hypertriglyceridemia
hypercholesterolemia
hypertriglyceridemia
hypercholesterolemia
hypercholesterolemia
hypertriglyceridemia
cardiovascular diseases
bone diseases
osteoporosis
bone diseases
osteoporosis
osteonecrosis
acidosis, lactic
mitochondrial diseases
immunotherapy
Interleukin-2
Interleukin-2
aids-related opportunistic infections
hepatitis C
hepatitis C
hepatitis C
ribavirin
ribavirin
interferons
interferons
hepatitis B
hepatitis B
hepatitis B
hepatitis A
hepatitis, chronic
liver cirrhosis
aids-related opportunistic infections
biopsy, needle
cause of death
pneumonia, pneumocystis
toxoplasmosis, cerebral
chemoprevention
tuberculosis
cryptococcosis
cytomegalovirus infections
antibiotic prophylaxis
candidiasis
leishmaniasis, visceral
intestinal diseases, parasitic
hiv infections
acquired immunodeficiency syndrome
mycobacterium infections
herpesvirus 8, human
herpes simplex
health services accessibility
transients and migrants
patient rights
poverty
socioeconomic factors
housing
insurance
prisons
prisoners
hospitalization
patient care
Long-Term care
herpesviridae infections
uterine cervical neoplasms
anus neoplasms
hodgkin disease
vaccination
vaccination
pneumococcal vaccines
meningococcal vaccines
haemophilus vaccines
hepatitis B vaccines
hepatitis A vaccines
BCG vaccine
yellow fever vaccine
signs and symptoms
HIV-2
pregnancy
risk assessment
prenatal diagnosis
infectious disease transmission, vertical
child
pregnancy complications
adolescent
infant, newborn
infant, newborn, diseases
hiv infections
acquired immunodeficiency syndrome
women
reproductive techniques, assisted
contraception
sexuality
sexual behavior
sexually transmitted diseases
sexual dysfunction, physiological
martinique
guadeloupe
french guiana
pregnancy, multiple
Contraindications, Procedure
Contraindications, Drug
HIV seropositivity
lymphoma, Non-Hodgkin
medication adherence
coinfection
practice guideline
---